BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nie K, Yang YY, Deng MZ, Wang XY. Gastrointestinal insights during the COVID-19 epidemic. World J Clin Cases 2020; 8(18): 3934-3941 [PMID: 33024750 DOI: 10.12998/wjcc.v8.i18.3934]
URL: https://www.wjgnet.com/2307-8960/full/v8/i18/3934.htm
Number Citing Articles
1
Zheng Li, Xingye Li, Jianxiong Shen, Matthew T.V. Chan, William Ka Kei Wu. Miller Fisher syndrome associated with COVID-19: an up-to-date systematic reviewEnvironmental Science and Pollution Research 2021; 28(17): 20939 doi: 10.1007/s11356-021-13233-w
2
Fei Chen, Zhiqing Dai, Chaofan Huang, Huiran Chen, Xinyi Wang, Xinya Li. Gastrointestinal Disease and COVID-19: A Review of Current EvidenceDigestive Diseases 2022; 40(4): 506 doi: 10.1159/000519412
3
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?International Immunopharmacology 2023; 116: 109597 doi: 10.1016/j.intimp.2022.109597
4
Ming-Ke Wang, Hai-Yan Yue, Jin Cai, Yu-Jia Zhai, Jian-Hui Peng, Ju-Fen Hui, Deng-Yong Hou, Wei-Peng Li, Ji-Shun Yang. COVID-19 and the digestive system: A comprehensive reviewWorld Journal of Clinical Cases 2021; 9(16): 3796-3813 doi: 10.12998/wjcc.v9.i16.3796
5
Siddharth Sridhar, John Nicholls. Pathophysiology of infection with SARS‐CoV‐2—What is known and what remains a mysteryRespirology 2021; 26(7): 652 doi: 10.1111/resp.14091
6
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, Amir Hossein Abdolghaffari. Mammalian target of rapamycin-novel insight for management of inflammatory bowel diseasesWorld Journal of Pharmacology 2022; 11(1): 1-5 doi: 10.5497/wjp.v11.i1.1
7
Marek Kieliszek. Selenium in the Prevention of SARS-CoV-2 and Other VirusesBiological Trace Element Research 2023; 201(2): 655 doi: 10.1007/s12011-022-03208-4